On November 27, 2013, President Obama signed the Drug Quality and Security Act, which amends the Food, Drug, and Cosmetic Act. The bill was originally introduced in the House of Representatives (as H.R. 3204) and significantly alters the regulation of compounded drugs.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
